Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 5, 2003, Pages 1294-1299

  Chen, Changhu ^a   Shu, Hui Kuo G ^a   Goldwein, Joel W ^a   Womer, Richard B ^b   Maity, Amit ^a,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Radiotherapy; Rhabdomyosarcoma

Indexed keywords

BIOPSY; CHEMOTHERAPY; PEDIATRICS; RADIOTHERAPY; TUMORS;

EXTERNAL BEAM RADIOTHERAPY;

ONCOLOGY;

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGE; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTRACRANIAL TUMOR; MALE; PEDIATRICS; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RHABDOMYOSARCOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 0037376120     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04290-6     Document Type: Article

References (15)

1. Tefft M., Fernandez C., Donaldson M., et al. Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children A report of the Intergroup Rhabdomyosarcoma Study (IRS). Cancer. 42:1978;253-258.
2. Chan R.C., Sutow W.W., Lindberg R.D. Parameningeal rhabdomyosarcoma. Radiology. 131:1979;211-214.
3. Berry M.P., Jenkin R.D. Parameningeal rhabdomyosarcoma in the young. Cancer. 48:1981;281-288.
4. Rodary C., Gehan E.A., Flamant F., et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children A report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol. 19:1991;89-95.
5. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
6. Cox D.R. Regression models and life tables. J R Stat Soc B. 34:1972;187-220.
7. Mandell L., Ghavimi F., Peretz T., et al. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy. J Clin Oncol. 8:1990;1536-1542.
8. Regine W.F., Fontanesi J., Kumar P., et al. Local tumor control in rhabdomyosarcoma following low-dose irradiation Comparison of group II and select group III patients. Int J Radiat Oncol Biol Phys. 31:1995;485-491.
9. Crist W., Gehan E.A., Ragab A.H., et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 13:1995;610-630.
10. Donaldson S.S., Meza J., Breneman J.C., et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - A report from the IRSG. Int J Radiat Oncol Biol Phys. 51:2001;718-728.
11. Heyn R., Ragab A., Raney R.B. Jr, et al. Late effects of therapy in orbital rhabdomyosarcoma in children A report from the Intergroup Rhabdomyosarcoma Study. Cancer. 57:1986;1738-1743.
12. Kaste S.C., Hopkins K.P., Bowman L.C. Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol. 25:1995;96-101.
13. Tefft M., Lattin P.B., Jereb B., et al. Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma. Cancer. 37:1976;1201-1217.
14. Raney R.B., Asmar L., Vassilopoulou-Sellin R., et al. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and -III. Med Pediatr Oncol. 33:1999;362-371.
15. Wharam M.D., Hanfelt J.J., Tefft M.C., et al. Radiation therapy for rhabdomyosarcoma Local failure risk for clinical group III patients on Intergroup Rhabdomyosarcoma Study II. Int J Radiat Oncol Biol Phys. 38:1997;797-804.